Are we treating women with postmenopausal osteoporosis for their low BMD or high fracture risk?
Bone
Henry G
HG
Santora
Arthur C
AC
Chattopadhyay
Arghya
A
Liberman
Uri
U
D019386:Alendronate / Q000627:therapeutic use; D015519:Bone Density / Q000187:drug effects*; D050071:Bone Density Conservation Agents / Q000627:therapeutic use; D005260:Female; D050723:Fractures, Bone / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D015663:Osteoporosis, Postmenopausal / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism; D012307:Risk Factors
D050071:Bone Density Conservation Agents; D019386:Alendronate